Table 1 Number, rate, and age-standardised rate for NASH-related HCC incidences, prevalence, DALYs and deaths in 2019
Male | Female | Total | |
|---|---|---|---|
Incidence | |||
Number, in thousands | 18.6 (14.9, 23.5) | 17.7 (14.0, 22.0) | 36.3 (29.5, 44.9) |
Rate, per 100,000 | 0.479 (0.385, 0.607) | 0.460 (0.364, 0.570) | 0.470 (0.381, 0.580) |
Age-standardised rate, per 100,000 | 0.493 (0.395, 0.622) | 0.407 (0.322, 0.503) | 0.448 (0.365, 0.554) |
Prevalence | |||
Number, in thousands | 24.6 (19.9, 30.9) | 22.2 (17.7, 27.3) | 46.8 (38.2, 57.6) |
Rate, per 100,000 | 0.635 (0.512, 0.796) | 0.575 (0.460, 0.709) | 0.605 (0.494, 0.744) |
Age-standardised rate, per 100,000 | 0.641 (0.518, 0.805) | 0.512 (0.410, 0.629) | 0.573 (0.467, 0.705) |
DALYs | |||
Number, in thousands | 417 (336, 520) | 378 (309, 471) | 796 (657, 976) |
Rate, per 100,000 | 10.8 (8.65, 13.4) | 9.81 (8.00, 12.2) | 10.3 (8.49, 12.6) |
Age-standardised rate, per 100,000 | 10.6 (8.50, 13.2) | 8.76 (7.15, 10.9) | 9.64 (7.98, 11.8) |
Deaths | |||
Number, in thousands | 17.4 (14.0, 22.0) | 17.4 (13.8, 21.8) | 34.7 (28.4, 43.2) |
Rate, per 100,000 | 0.448 (0.360, 0.567) | 0.450 (0.358,0.565) | 0.449 (0.367, 0.558) |
Age-standardised rate, per 100,000 | 0.470 (0.380, 0.593) | 0.397 (0.317, 0.499) | 0.431 (0.353, 0.534) |